July 29, 2019 | Letisia Marquez
City of Hope has been named the best cancer hospital in the West by U.S. News & World Report’s 2019-20 Best Hospitals: Specialty Ranking. This marks the 13th consecutive year it has been distinguished as one of the nation’s elite cancer hospitals.
A blood test for cancer? New department focuses on early detection
September 19, 2019 | Maxine Nunes
Dynamic and passionate — with a formidable track record of innovations in cancer care — Ajay Goel, Ph.D., M.S., has recently joined the staff at City of Hope, and he’s hit the ground running.
Certain colorectal patients may benefit from immunotherapy
September 16, 2019 | Zen Vuong
People with colon and rectal tumors prone to “immune overdrive” don’t do well if they concurrently have an immune-suppressive tumor microenvironment, City of Hope researchers say.
Study finds most aren't upset by learning genetic test results
September 10, 2019 | Letisia Marquez
A National Institutes of Health-funded study led by City of Hope’s Stacy Gray, M.D., examined a person’s emotional state before they received test results and after. Researchers found that anxiety and depression did not increase significantly following genetic test result disclosure.
City of Hope and NASA are studying microbes in space
September 5, 2019 | Maxine Nunes
Learning about the mechanisms terrestrial bacteria and fungi use to survive in the challenging environment of outer space could give us insights into how to fight disease, as well as how to promote beneficial bacterial growth.
New study finds genomic link between diabetes and cancer
August 27, 2019 | Zen Vuong
City of Hope's John Termini, Ph.D., presents research at the American Chemical Society annual meeting that could explain why diabetes patients have an increased risk of developing some forms of cancer.
Researcher receives $1.35M Department of Defense grant for breast metastasis study
August 20, 2019 | Michael Easterling
Rahul Jandial, M.D., Ph.D., has received the “Breakthrough” award from the Department of Defense's Breast Cancer Research Program to support his study of leptomeningeal disease, which is characterized by the spreading of tumor cells to the lining of the brain and spinal cord.
City of Hope enrolling patients in clinical trial for HPV-linked cancers
August 20, 2019 | Letisia Marquez
A first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is now open at City of Hope. The institution is the first to open such a trial on the West Coast.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas
August 14, 2019 | Jenny Peters
City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.
New ‘liquid biopsy’ blood test could improve breast cancer diagnostics
August 7, 2019 | Letisia Marquez
Developed by TGen and partners, the test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer. It works by measuring tiny particles of tumor DNA circulating in a patient's bloodstream.